<DOC>
	<DOCNO>NCT00640640</DOCNO>
	<brief_summary>One concern repeat intravitreal injection bevacizumab ( Avastin ) ranibizumab ( Lucentis ) wet age relate macular degeneration , addition block protein trigger development proliferation abnormal vessel center retina , may also result change normal vessel feed outer part retina . Small vessel fenestration ( fee outer part retina , call choriocapillaris ) appear especially sensitive protein ( call vascular endothelial growth factor , VEGF ) withdrawal . It estimate global blood flow vascular layer retina ( call choroid ) may indirectly assess measure amplitude ocular pulsation ( pressure inside eye change accord cardiac cycle , similar change blood pressure ) call Ocular Pulse Amplitude ( OPA ) . The Pascal Dynamic Contour Tonometer ( Pascal DCT ) new tonometer ( device measure pressure within eye ) design measure intraocular pressure ocular pulse amplitude . No publish study yet assess effect bevacizumab ( Avastin ) ranibizumab ( Lucentis ) treatment wet AMD ( retinal disease ) OPA . This aim pilot study , measure pressure within eye prior bevacizumab/Ranibizumab treatment , follow repeat measurement week month treatment . For purpose , 60 patient wet AMD recruit .</brief_summary>
	<brief_title>The Effects Bevacizumab Ranibizumab Ocular Pulse Amplitude Neovascular Age Related Macular Degeneration ( AMD )</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>1 . Male female age 50 year old 2 . Willing able sign inform consent 1 . Any history , sign symptoms retinal optic nerve disease , except AMD mild hypertensive retinopathy 2 . In presently bevacizumab/ranibizumab treat eye , prior PDT and/or intravitreal Kenalog , last 3 month . 3 . History ocular surgery follow exception : extra capsular cataract extraction implantation posterior chamber intraocular lens . 4 . History ocular laser treatment , follow exception : Posterior capsulotomy follow cataract surgery . 5 . Cataract medium opacity preclude adequate fundus visualization eye</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>IOP</keyword>
	<keyword>OPA</keyword>
	<keyword>AMD</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>ranibizumab</keyword>
	<keyword>choroidal blood flow</keyword>
	<keyword>DCT</keyword>
	<keyword>Ocular Pulse Amplitude change follow anti VEGF</keyword>
	<keyword>Ocular Pulse Amplitude</keyword>
</DOC>